Emerald Bioscience Earnings Per Share vs. Working Capital
Based on the measurements of profitability obtained from Emerald Bioscience's financial statements, Emerald Bioscience may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in May. Profitability indicators assess Emerald Bioscience's ability to earn profits and add value for shareholders.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
Please note, there is a significant difference between Emerald Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Emerald Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emerald Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
For Emerald Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Emerald Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Emerald Bioscience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Emerald Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Emerald Bioscience over time as well as its relative position and ranking within its peers.
Emerald |
Emerald Bioscience Working Capital vs. Earnings Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Emerald Bioscience's current stock value. Our valuation model uses many indicators to compare Emerald Bioscience value to that of its competitors to determine the firm's financial worth. Emerald Bioscience is considered to be number one stock in earnings per share category among related companies. It is considered to be number one stock in working capital category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Emerald Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emerald Bioscience's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Emerald Bioscience's earnings, one of the primary drivers of an investment's value.Emerald Working Capital vs. Earnings Per Share
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Emerald Bioscience |
| = | (0.16) X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Emerald Bioscience |
| = | (206 K) |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Emerald Working Capital Comparison
Emerald Bioscience is currently under evaluation in working capital category among related companies.
Emerald Bioscience Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Emerald Bioscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Emerald Bioscience will eventually generate negative long term returns. The profitability progress is the general direction of Emerald Bioscience's change in net profit over the period of time. It can combine multiple indicators of Emerald Bioscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nemus Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company was founded in 2012 and is headquartered in Long Beach, California. Nemus Bioscience operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 3 people.
Emerald Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Emerald Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Emerald Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Emerald Bioscience's important profitability drivers and their relationship over time.
Use Emerald Bioscience in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emerald Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emerald Bioscience will appreciate offsetting losses from the drop in the long position's value.Emerald Bioscience Pair Trading
Emerald Bioscience Pair Trading Analysis
The ability to find closely correlated positions to PNC Financial could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PNC Financial when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PNC Financial - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PNC Financial Services to buy it.
The correlation of PNC Financial is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PNC Financial moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PNC Financial Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PNC Financial can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Emerald Bioscience position
In addition to having Emerald Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Emerald OTC Stock
If you are still planning to invest in Emerald Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Bioscience's history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |